We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK to Market Roche's Xenical; OTC Application Expected by Mid-2005
GSK to Market Roche's Xenical; OTC Application Expected by Mid-2005
April 12, 2005
GlaxoSmithKline (GSK) has finalized a deal to market a prescription version of Roche’s leading weight-loss drug Xenical in the U.S., the companies announced April 12.